Day: June 15, 2021

Nexen Tire N’FERA SPORT Golf and Leon approved by VW and Leon

SEOUL, South Korea, June 15, 2021 (GLOBE NEWSWIRE) — Nexen Tire, a leading global tire manufacturer, today announced that the N’FERA SPORT will feature as original equipment on Volkswagen’s eighth generation Golf and SEAT’s fourth generation Leon, fitted in size 225/45R17 91W.

The Golf, also known as the “Hot Hatch,” is Volkswagen’s flagship model and has sold over 35 million units since its launch in 1979. Meanwhile, the Leon is a representative hatchback model of Spanish automotive company SEAT, with over 2 million units sold since launching in 1999.

The N’FERA SPORT is designed for European sports vehicles, providing outstanding performance and safety during high-speed driving. In particular, this product is characterized by excellent handling and braking performance, even during sudden stops.

The tire has received a tally of accolades of strong ratings and results, including from top German automotive magazine Auto Club Europa (ACE) Lenkrad which recently rated the N’FERA SPORT in first place in the summer tire test.

Meanwhile, Nexen Tire is continuing to increase its OE supply across all countries in Europe.

About Nexen Tire

Nexen Tire, established in 1942, is a global tire manufacturer headquartered in South Korea. Nexen Tire, one of the world’s fastest growing tire manufacturers, currently interacts with approximately 150 countries around the world and owns four manufacturing plants – two in Korea (Yangsan and Changnyeong) and one in Qingdao, China. Another plant in Žatec, the Czech Republic has also begun operation in 2019. Nexen Tire produces tires for passenger cars, SUVs, and light trucks with advanced technology and excellence in design. Nexen Tire supplies OE tires to global car makers in various countries around the world. In 2014, the company achieved a grand slam of the world’s top 4 design awards for the first time amongst the various tire makers in the world.

For more information, please visit https://www.nexentire.com/international/

CONTACT: Sylvia Chang, sylvia.chang@pivotp.co.kr

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0f20b5d8-f6e9-49c0-a657-09865c6b3295

VistaJet Business

New report measures value of business travel for first time

London, June 15, 2021: Only 24 months ago, business travel was synonymous with global corporations and senior executives’ roles. During the global lockdowns, companies have experienced the direct impact of no travel or in-person meetings on their business functions and operations. In new research from VistaJet, the first and only global business aviation company, in association with WSJ Intelligence, that impact is quantified for the first time.

For The Future of Business Travel report over 200 high-level company executives in the U.S., EMEA and APAC were surveyed about the essential role and value of travel in their professional lives.

During the pandemic, travel has been limited for 90% of companies surveyed, and almost all (97%) said their businesses experienced negative impact directly related to those restrictions. Nearly one-quarter (24%) indicated massive or substantial disruptions across all eight areas measured, and 87% cited massive or substantial disruption in at least one area. More than a third (37%) said international business development and product launches took a hit due to a lack of in-person presence.

As restrictions ease, built-up anticipation for business travel is clear, with 81% saying business travel will be more important than ever to driving success. Among respondents who take eight or more private flights a year, 60% plan to significantly increase in-person meetings.

VistaJet Global 7500

VistaJet has seen a surge of 49% in corporate interest around the world since the start of the pandemic, confirming that flying private continues to be a key support for business travel. The main benefits of taking private flights for business travel are reported by those surveyed, in order, as flexibility, efficiency, safety and privacy. The two top priorities for trips are visiting partners and vendors and going to industry events, each at 34%. Managing current relationships and building new ones are also key drivers.

The return to business travel largely hangs on regulations — 46% of respondents are waiting for destinations to reopen; 42% want updated COVID-19 data and rules for destinations; 36% seek support in case COVID-19 regulations change during a trip; and the same number await relaxation of their own company’s travel policies.

Ian Moore, Chief Commercial Officer, VistaJet said: “The COVID-19 pandemic has upended the world, including travel. It also showed that some business travel is truly essential and having to forgo in-person trips came at a real cost to companies. Additionally, it is hard to read a room when everyone is in individual windows on screen — misunderstandings can occur, especially across cultures, and these in turn can become costly mistakes.”

To further support businesses around the world connect and restart the economy in the midst of heightened market insecurity, VistaJet recently launched a new Corporate Membership, offering speed and maximum flexibility with payment in arrears, unlimited flying hours, guaranteed availability of additional aircraft, and streamlined travel logistics.

For the full findings of The Future of Business Travel report, and to download a copy, please visit vistajet.com/businesstravel.

Information
Jennifer Farquhar | VistaJet | press@vistajet.com

About VistaJet
VistaJet is the first and only global business aviation company. On its fleet of over 70 silver and red business jets, VistaJet has flown corporations, governments and private clients to 187 countries, covering 96% of the world. Founded in 2004, the company pioneered an innovative business model where customers have access to an entire fleet whilst paying only for the hours they fly, free of the responsibilities and asset risks linked to aircraft ownership. VistaJet’s signature Program membership offers customers a bespoke subscription of flight hours on its fleet of mid and long-range jets, to fly them anytime, anywhere.
VistaJet is part of Vista Global Holding — the world’s first private aviation ecosystem, integrating a unique portfolio of companies offering asset-light solutions to cover all key aspects of business aviation.
More VistaJet information and news at vistajet.com

VistaJet Limited is a European air carrier that operates 9H registered aircraft under its Maltese Air Operator Certificate No. MT-17 and is incorporated in Malta under Company Number C 55231. VistaJet and its subsidiaries are not U.S. direct carriers. VistaJet-owned and U.S. registered aircraft are operated by properly licensed U.S. air carriers, including XOJET Aviation LLC.

Attachments

• VistaJet Business
• VistaJet Global 7500
• VistaJet Technology

PETALING JAYA, Malaysia, June 14, 2021 (GLOBE NEWSWIRE) — Toga Limited (OTC: TOGL) through its wholly owned subsidiary, TOGL Technology Sdn Bhd, collaborates with a renowned cloud computing company and an electronic Know-Your-Customer (e-KYC) technology provider to expediate the online process of identifying and verifying individuals from five days to 24 hours, for its social media mobile app, Yippi.

The strategic partnership enables the Yippi customer service (CS) team to reduce the turnaround time for the online process of identifying and verifying individuals anytime and anywhere, as the e-KYC system allows new users to open a Yippi account and verify their identities simply by scanning their national identity card and taking a photo.

“With the e-KYC system in place, we are able to reduce identity fraud by means of its comprehensive ID document security check; comprehensive artificial intelligence (AI) model specifically facial recognition, and risk engine that can identify frauds automatically, hence speeding up approval notifications for our CS team with the necessary information to approve or reject applications, as needed,” said TOGL Technology Chief Technology Officer, Mr. Freddy Chia Kah See.

“Additionally, under special circumstances, our team also conducts e-KYC to utilize technology like AI, machine learning and predictive algorithms to manage the process,” he added.

“The introduction of e-KYC is also in line with our efforts to facilitate greater digital offerings of Yippi services, and we expect it will pave the way to greater innovation in the social media app sector, including end-to-end offerings of digital services for our users,” said Mr. Chia.

Yippi applies an e-KYC digital and remote online solution system, which combines biometrics security technology, “spoof detection” and optical character recognition. Biometric security analyzes the unique characteristics of a person, such as one’s voice, iris or fingerprints. Spoof detection, also called “liveness”, entails a user responding to a challenge, such as blinking on cue, which is an action impossible for a static image a fraud might use. Optical character recognition transforms a picture of an ID card into text that can be compared against a database for name and identity verification.

Contact:

Alexander D. Henderson
TOGA LIMITED, 515 S. Flower Street, 18^th Floor, Los Angeles, CA 90071
(949) 333-1603
info@togalimited.com

Certain statements in this press release are forward-looking as defined in the Private Securities Litigation Reform Act of 1995. Any statements contained herein that are not statements of historical fact (including, but not limited to, statements to the effect that Toga Limited or its management (the “Company”) “anticipates,” “plans,” “estimates,” “expects,” or “believes,” or the negative of these terms and other similar expressions) should be considered forward-looking statements, including, without limitation, statements regarding the Company’s guidance, outlook, growth, opportunities and long-term strategy. These statements involve certain risks and uncertainties that may cause actual results to differ materially from expectations as of the date of this release. These risks and uncertainties include, without limitation, risks associated with the impact of the COVID-19 pandemic; the Company’s ability to execute on its long-term strategy; the Company’s ability to successfully compete in its intensely competitive industry; the Company’s ability to manage its growth; the Company’s ability to maintain or improve its operating margins; the Company’s ability to identify and react to trends in consumer preferences; product supply disruptions; general economic conditions; accounting standard changes; and other factors as set forth from time to time in the Company’s Securities and Exchange Commission filings, including, without limitation, the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company intends these forward-looking statements to speak only as of the time of this Press Release and does not undertake to update or revise them as more information becomes available, except as required by law.

Jeito Capital becomes key investor in Alentis Therapeutics as part of $67 million Series B financing round

• Jeito Capital selects Alentis Therapeutics as its fifth investment since launching the fund
• Alentis is focused on the development of breakthrough treatments for fibrotic diseases and associated cancers

Paris, France, 15 June 2021 – Jeito Capital (“Jeito”), a rapidly emerging independent Private Equity firm dedicated to biotech and biopharma, today announces that it has become a key investor as part of a $67 million Series B financing round in Alentis Therapeutics (Alentis). The Swiss biotech company, a spin-off of French Inserm with R&D in Strasbourg, France, is developing breakthrough therapies for patients suffering from fibrotic diseases and associated cancers.

Proceeds from the financing round will be used for proof-of-concept clinical trials of Alentis’ first-in-class assets, uniquely targeting fibrosis pathways for the treatment of life-threatening advanced liver and kidney fibrosis as well as associated cancers. Alentis expects to initiate its first clinical trial by the end of 2021.

Jeito’s investment aims to enable Alentis to accelerate the clinical pathway for various indications, with the potential to provide life-changing treatments to severely ill patients who have no other options. The investment will also give the Company the opportunity to expand its pipeline and explore further indications, including fibrotic associated cancers.

The financing round brings in Jeito Capital and Morningside Venture Investments alongside existing investors BioMed Partners, BB Pureos Bioventures, Bpifrance, High-Tech Gründerfonds and Schroders Capital. Following the fundraise, Rafaèle Tordjman, Founder and CEO of Jeito Capital, will join Alentis’ Board of Directors.

This is Jeito’s fifth investment since launching its fund in 2020. With more than €250 million under management, Jeito Capital is building a strong and diversified portfolio in biotech and biopharma companies based in Europe with global reach focused on the treatment of life-threatening diseases. Previous investments include French companies SparingVision and InnoSkel, respectively in the fields of ophthalmology and rare skeletal disorders, Dutch biotech Neogene Therapeutics in solid tumors, and recently Pulmocide in respiratory diseases, based in the UK.

Alentis is led by a highly experienced management team from the biotech and pharma industries. The Company’s science is based on more than 10 years of research by founder Thomas Baumert, a world class hepatology expert who currently serves as the head of Inserm’s Institute of Viral and Liver Diseases. Prof. Baumert’s research in Claudin-1 is unique and, until now, has not been explored as a potential treatment target for fibrotic diseases.

Rafaèle Tordjman, founder and CEO of Jeito, said: “Our investment in Alentis at this pivotal time of development will be crucial for its success and we are looking forward to working closely alongside their very experienced team. Our expertise lies in helping management teams from the science right through to commercialization of the product and here we will aim to accelerate Alentis’ efforts towards the initiation of the company’s first clinical trials. This represents our fifth investment in our diverse portfolio and strengthens our commitment to investing in European biotechs working towards the development of life–saving assets targeted at diseases with unmet need based on outstanding science.”

Dr. Roberto Iacone, Chief Executive Officer at Alentis Therapeutics, said: “We are delighted to have closed this financing round with new investors Jeito Capital and Morningside Venture Investments, two well respected and highly knowledgeable institutions within the healthcare space who will bring invaluable experience to the Board as we progress towards the initiation of our first clinical trials. Building on 20 years of work and positive preclinical data collected on ALE.F02, we are confident in the success of the upcoming trials as we work with both new and existing investors towards commercialization, providing a much needed safe and effective treatment to patients suffering from fibrotic diseases and hepatobiliary cancers.”

About Jeito Capital
Jeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates ground-breaking medical innovation. Jeito empowers and supports entrepreneurs through its expert, integrated, multi-talented team and through the investment of significant capital to ensure the growth of companies, building market leaders in their respective therapeutic areas with accelerated patients’ access in Europe & the United States. Jeito Capital is based in Paris with a presence in Europe and the United States. For more information, please visit www.jeito.life, or follow on Twitter @Jeito_life or LinkedIn.

About Alentis Therapeutics
Alentis Therapeutics is a Swiss-based biotech that focuses on developing breakthrough treatments for fibrotic diseases. The company was founded in 2019 based on ground-breaking research in the laboratory of Prof. Thomas Baumert MD at the University of Strasbourg and the French National Institute of Health (Inserm).

The company’s lead candidates are monoclonal antibodies that are highly selective for Claudin-1, a novel, previously unexploited target with a unique mechanism of action that plays a key role in the pathology of liver fibrosis and fibrosis-driven hepatobiliary cancers. It also has early discovery programs exploring the potential of Claudin-1 inhibition in the treatment of fibrosis of other tissues including the kidney and lung. These represent very large and expanding markets with high unmet need. Furthermore, the company uses a patient-derived drug and target discovery platform to develop medicines for advanced fibrosis.

Unlike current therapies in fibrosis, which mostly address the disease indirectly, Alentis’ pioneering approach has the potential to directly modify and reverse the course of disease progression.

Alentis is headquartered in Basel’s pharma-biotech hub in Switzerland with a subsidiary for R&D in Strasbourg, France.

For more information, visit https://alentis.ch/

For more information please contact:

Jeito Capital Rafaèle Tordjman, Founder and CEO contact@jeito.life Consilium Strategic Communications Mary-Jane Elliott / Melissa Gardiner / Davide Salvi / Kris Lam Jeito@consilium-comms.com

Tel: + 33 (0) 6 35 36 35 00 Tel: +44 (0) 20 3709 5700

LeddarTech joins Tech.AD Europe as the Lead Sponsor and as both a presenter and exhibitor at this live event at the Titanic Chaussee Berlin, Germany, on July 1-2, 2021. Join LeddarTech either in person or digitally by registering today at autonomous-driving-berlin.com.

QUEBEC CITY, June 15, 2021 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in Level 1-5 ADAS and AD sensing technology, is excited to be reigniting its physical event calendar as a lead sponsor and keynote speaker of Tech.AD. Tech.AD has long been recognized as one of Europe’s leading technical ADAS and AD conferences. LeddarTech’s CTO Pierre Olivier will serve on the honorary jury for the 8^th Annual Tech.AD Europe Awards. These awards honor individuals and organizations who have designed exceptional solutions or products that contribute to ADAS/AD automotive development.

With a focus on environmental sensing that reimagines ADAS and AD solutions, the LeddarTech team will be participating in several capacities at this event.

Keynote presentation: July 1, 2021, 4:45 p.m. – 5:05 p.m. CET

Topic: Sensing Modalities, Sensor Fusion, and Perception for Autonomous Driving. The speaker, Pierre Olivier, Chief Technology Officer of LeddarTech, will explore the challenges and exciting opportunities facing the ADAS and AD business community.

World Café session: July 2, 2021, 1:15 p.m. – 3:35 p.m. CET

Topic: Sensor Café – Object Fusion vs. Raw Sensor Fusion – What Is the Superior Solution? Moderators: Reza Rashidi Far, PhD, and André Malz, PhD, of LeddarTech’s Strategic Product Management division.

Exhibition booth (6): July 1-2, 2021.

LeddarTech will feature solutions that solve critical sensing and perception challenges across the automotive and mobility value chain. LeddarTech will present these solutions through an innovative approach of on-site and live-streaming demonstrations of:

• Mobility and ITS sensors, including the recently released Leddar™ Sight LiDAR and the award-winning Leddar™ Pixell;
• LeddarVision™, a sensor-fusion and perception solution that delivers highly accurate 3D environmental models for L1-5 autonomy;
• Special Feature: the Westfield AutoSweep, the UK’s first fully autonomous pure electric road sweeper, featuring the Leddar Pixell.

“Our technical teams from Israel, Germany, and Italy are excited to be joining our esteemed colleagues, peers, and partners at Tech.AD. Our much-anticipated return to in-person events is especially significant as we will be showcasing our customer Westfield’s autonomous AutoSweep POD, which features the Leddar Pixell,” stated Daniel Aitken, Vice-President, Global Marketing, Communications, and Product Management at LeddarTech. “Tech.AD provides an excellent opportunity to engage with many leaders in the industry both virtually and in person, and we look forward to demonstrating our latest technology, sharing our vision, and engaging with our customers,” Mr. Aitken continued. “Tech.AD is making all efforts to implement precautions to ensure a safe and fulfilling event for all delegates, and I welcome you to visit us in person or online during the event in July,” concluded Mr. Aitken.

For more information about Tech.AD, visit autonomous-driving-berlin.com.

Prior to Tech.AD register for the Automotive IQ Webinar: June 29, 2021, 11:00 a.m. – 12:00 p.m. ET

Topic: A Clean Sweep: How Adopting Autonomous Vehicle and EV Technology Is Paving the Way to Increased Road Sweeper Efficiency and Safety While Reducing Environmental Impact. Join Pierre Olivier, CTO of LeddarTech and Julian Turner, CEO of Westfield Technology Group, for this Automotive IQ hosted event.

Register here.

About LeddarTech

LeddarTech is a leader in environmental sensing platforms for autonomous vehicles and advanced driver assistance systems. Founded in 2007, LeddarTech has evolved to become a comprehensive end-to-end environmental sensing company by enabling customers to solve critical sensing and perception challenges across the entire value chain of the automotive and mobility market segments. With its LeddarVision™ sensor-fusion and perception platform and its cost-effective, scalable, and versatile LiDAR development solution for automotive-grade solid-state LiDARs based on the LeddarEngine™, LeddarTech enables Tier 1-2 automotive system integrators to develop full-stack sensing solutions for autonomy level 1 to 5. These solutions are actively deployed in autonomous shuttles, trucks, buses, delivery vehicles, smart cities/factories, and robotaxi applications. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 95 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook, and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications, and Product Management, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232
daniel.aitken@leddartech.com

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, VAYADrive, VayaVision, and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/2f336faf-ccca-4167-939e-c1dfcfc4c897

https://www.globenewswire.com/NewsRoom/AttachmentNg/84aebadf-f893-466e-8144-9b31e4d79c26